All articles tagged with #mergers acquisitions
An opinion piece argues Sun Valley, the annual media moguls’ gathering, has become a breeding ground for flawed megadeals that enrich bankers while harming shareholders and consumers, highlighting NBCUniversal, Time Warner/Warner Bros. Discovery, and AT&T as emblematic misfires and noting how such deals often fail to deliver lasting value.
Comcast announced spin-offs of NBCUniversal and Sky while retaining the cable business, a move analysts say could unlock a wave of mergers and acquisitions as the separated companies become easier to buy, sell, or combine; bankers preview potential moves like Comcast expanding via Charter and possibly selling NBCU to Netflix to bolster a stronger distribution/content platform in a shifting media landscape.
Chip stocks rebound as Goldman Sachs racks up a string of M&A wins, signaling renewed momentum in tech shares and corporate dealmaking.
Comcast plans to separate its cable business from NBCUniversal and Sky to unlock value and growth, while insisting the move isn’t a prelude to imminent M&A. The spin-off could create deal options years down the line, with Charter’s stock rally fueling speculation of a Comcast–Charter tie-up, but executives and analysts warn regulatory hurdles and debt considerations keep near-term megadeals unlikely.
A Los Angeles County report warns the Paramount-WBD merger could threaten about 2,500 local jobs and 6,000 globally due to duplicative roles amid an $82 billion debt, with only limited near-term production gains; it recommends commitments to local job growth and tax incentives to keep film/TV work in California.
The DOJ approved Paramount Skydance’s $111 billion acquisition of Warner Bros. Discovery after an eight-month antitrust review, arguing the deal would boost competition; WSJ reports say career antitrust staff favored challenging the merger and were overruled, with Ellison’s meeting cited as influential. Critics including Sen. Warren allege political favoritism, while states and EU regulators plan challenges and closer scrutiny.
Netflix stock fell after reports that Fox won a $22 billion deal to acquire Roku, a move seen as part of a broader consolidation in streaming and distribution. The outcome underscores Netflix’s shift from internal growth to potential acquisitions, following a recent Warner Bros. Discovery pursuit and with Lionsgate eyeing interest, while regulators would scrutinize such a merger for antitrust concerns.
American Express announced a proposed acquisition of TheFork, a leading European restaurant booking platform.
Fox Corp agreed to acquire Roku for about $22 billion, paying $160 per share in cash and Fox Class A stock. Upon closing, Fox shareholders would own about 73% of the merged company and Roku holders about 27%, creating a scaled media/tech group anchored by live sports, news, Tubi and the Roku platform with roughly $400 million in run-rate cost synergies and a closing targeted for the first half of 2027. Roku will remain an open platform, and Roku founder Anthony Wood will join Fox's board as the deal integrates Fox’s sports and news assets with Roku's streaming technology.
Fox Corp will acquire Roku in a cash-and-stock deal valued at about $22 billion, at $160 per Roku share (11.4% premium). The move gives Fox access to Roku’s 100+ million streaming households to boost targeted advertising and diversify beyond traditional distribution, pairing Fox’s sports and news with Roku’s platform. The merged company would own about 73% of the equity for Fox shareholders and 27% for Roku shareholders, is expected to close in the first half of 2027, and would become the third-largest U.S. TV viewer share, with Fox already operating Tubi and Roku running The Roku Channel.
GSK agreed to acquire Nuvalent for $10.6 billion in cash, paying about $124 per share (roughly a 40% premium) to bolster its oncology pipeline and offset expected HIV revenue declines when its best-selling HIV medicine loses exclusivity in 2028. Nuvalent brings late-stage lung-cancer assets neladalkib and zidesamtinib, plus an early-stage and preclinical portfolio, with potential blockbusters if approved by the FDA. The deal would be GSK’s second-largest ever and signals a shift toward larger biotech deals amid strong M&A activity, with guidance unchanged for 2026 and growth anticipated from 2027.
United Airlines CEO Scott Kirby said a major merger with American Airlines is unlikely after American rebuffed the approach, though United may pursue asset buys such as airport slots or gates to weather higher fuel costs; any deal would require a willing partner, and he argued United’s edge comes from brand and product investments rather than its balance sheet, while denying discussions of a US government golden share and noting JetBlue’s Chapter 11 status makes it a less attractive target.
Billionaire Tilman Fertitta plans to acquire Caesars Entertainment for roughly $17.6 billion, paying $31 per share in cash and assuming about $11.9 billion of Caesars’ debt. Caesars’ board has approved the deal and recommends shareholders vote in favor, but it still requires regulatory and shareholder approvals, with a go-shop period through July 11, 2026. The takeover could bring debt restructuring and cost-cutting, leverage Fertitta’s hospitality network (Golden Nugget, Landry’s) and Caesars Rewards for broader cross-marketing, and potentially reshape the Las Vegas Strip through strategic divestitures and leadership changes over time; the deal could take up to a year to close.
IMAX is reportedly exploring a potential sale, with the Wall Street Journal noting preliminary talks via intermediaries and CNBC saying there’s no formal process yet. The news spiked its stock and points to interest from entertainment companies—potential buyers could include Disney, Apple, Amazon, or Netflix—though Disney’s Infinity Vision format complicates the fit. IMAX also posted strong numbers, with about $1.28 billion worldwide last year, underscoring premium-experience cinema’s pull even as the theater industry contends with changes.
Federal prosecutors unveiled indictments alleging a multimillion-dollar insider trading scheme that used nonpublic information about mergers and acquisitions handled by top law firms (including Goodwin Procter, Latham & Watkins, Sidley Austin, Wachtell Lipton, and Weil Gotshal) to trade on deals involving major companies such as Amazon, Johnson & Johnson, and eBay.